Pharmacologic Considerations for Antimicrobials and Anticoagulants after Burn Injury
Derangements in pharmacokinetics and pharmacodynamics (PK/PD) of burn patients are poorly understood and lacking consistent data. This leads to an absence of consensus regarding pharmacologic management of burn patients, complicating their care. In order to effectively manage burn critical illness,...
Saved in:
Main Authors: | Pranav Ravichandran (Author), Kaitlin A. Pruskowski (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticoagulants and acute kidney injury: clinical and pathology considerations
by: Sergey V. Brodsky
Published: (2014) -
Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings
by: O. V. Zhukova, et al.
Published: (2019) -
Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
by: Daniel J. Selig, et al.
Published: (2022) -
Recurrent Nevus After Burn Injury
by: Raquel Nardelli de Araújo, et al.
Published: (2019) -
Eruptive nevi after burn injury
by: Ali Tareen, et al.
Published: (2018)